Ewing's sarcoma of the head and neck: A systematic review.

OBJECTIVE The aim of the present study was to conduct a systematic review of head and neck Ewing sarcoma (ES) concerning patients' demographic and clinical features, histopathological findings, treatment, follow-up, and survival rate. MATERIALS AND METHODS An electronic search was undertaken in four databases. Articles describing case reports or case series were included. Outcomes were evaluated by the Kaplan-Meier method along with Cox regression. RESULTS The search yielded 186 studies describing 227 ES cases. The mean age was 22.7 years, and males were slightly more affected. Interestingly, more than half the cases were diagnosed up to 20 years. The respiratory tract was the most reported site, followed by the jawbones. Clinically, symptomatic swelling or nodules were described, with a mean duration of 4 months. Management involved multimodal treatment regimens. Local recurrence, lymph node and distant metastasis were observed in 10.7%, 12.6%, and 20.3% of cases, respectively. Statistical analysis revealed that older patients with distant metastasis had a lower overall survival rate (p < 0.05). CONCLUSION This study provides an overall view of head and neck ES that can assist oral and maxillofacial pathologists with the diagnosis and extend the knowledge of surgeons and oncologists about this condition.

[1]  A. Palmieri,et al.  Polymorphic variants of IGF2BP3 and SENCR have an impact on predisposition and/or progression of Ewing sarcoma , 2022, Frontiers in Oncology.

[2]  S. Sundaram,et al.  Incidence and Demographic Profile of Ewings Sarcoma: Experience From a Tertiary Care Hospital , 2021, Cureus.

[3]  P. Rutkowski,et al.  Age as a Prognostic Factor in Patients with Ewing Sarcoma—The Polish Sarcoma Group Experience , 2021, Journal of clinical medicine.

[4]  E. Mayo-Wilson,et al.  PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews , 2020, BMJ.

[5]  A. Folpe,et al.  Ewing Sarcoma in Older Adults: A Clinicopathologic Study of 50 Cases Occurring in Patients Aged ≥40 Years, With Emphasis on Histologic Mimics , 2019, International journal of surgical pathology.

[6]  B. Judson,et al.  Clinical characteristics and treatment‐associated survival of head and neck Ewing sarcoma , 2019, The Laryngoscope.

[7]  M. D. Olson,et al.  Ewing sarcoma of the head and neck: The Mayo Clinic experience , 2018, Head & neck.

[8]  F. Fonseca,et al.  Current update on the diagnosis and management of head and neck hard tissue sarcomas , 2017, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[9]  Havva Serap Toru,et al.  Primary extraskeletal Ewing's sarcoma of the maxillary sinus , 2016, Brazilian journal of otorhinolaryngology.

[10]  U. Dirksen,et al.  Management and Outcome of Ewing Sarcoma of the Head and Neck , 2016, Pediatric blood & cancer.

[11]  H. Ha,et al.  Imaging Features of Primary Tumors and Metastatic Patterns of the Extraskeletal Ewing Sarcoma Family of Tumors in Adults: A 17-Year Experience at a Single Institution , 2015, Korean journal of radiology.

[12]  David Moher,et al.  The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development , 2013, Journal of Medical Case Reports.

[13]  U. Dirksen,et al.  Ewing Sarcoma: Clinical State-of-the-Art , 2012, Pediatric hematology and oncology.

[14]  K. Pathak,et al.  Head and Neck Soft Tissue Sarcoma , 2011, Indian journal of surgical oncology.

[15]  J. Zell,et al.  Analysis of prognostic factors in Ewing sarcoma using a population‐based cancer registry , 2010, Cancer.

[16]  J. Ewing Diffuse endothelioma of bone , 1972 .